Author: Hiam-Galvez, Kamir J.; Allen, Breanna M.; Spitzer, Matthew H.
Title: Systemic immunity in cancer Cord-id: 8mfsct6k Document date: 2021_4_9
ID: 8mfsct6k
Snippet: Immunotherapy has revolutionized cancer treatment, but efficacy remains limited in most clinical settings. Cancer is a systemic disease that induces many functional and compositional changes to the immune system as a whole. Immunity is regulated by interactions of diverse cell lineages across tissues. Therefore, an improved understanding of tumour immunology must assess the systemic immune landscape beyond the tumour microenvironment (TME). Importantly, the peripheral immune system is required t
Document: Immunotherapy has revolutionized cancer treatment, but efficacy remains limited in most clinical settings. Cancer is a systemic disease that induces many functional and compositional changes to the immune system as a whole. Immunity is regulated by interactions of diverse cell lineages across tissues. Therefore, an improved understanding of tumour immunology must assess the systemic immune landscape beyond the tumour microenvironment (TME). Importantly, the peripheral immune system is required to drive effective natural and therapeutically induced antitumour immune responses. In fact, emerging evidence suggests that immunotherapy drives new immune responses rather than the reinvigoration of pre-existing immune responses. However, new immune responses in individuals burdened with tumours are compromised even beyond the TME. Herein, we aim to comprehensively outline the current knowledge of systemic immunity in cancer.
Search related documents:
Co phrase search for related documents- activating receptor and liver spleen: 1
- adaptive immune response and liver spleen: 1, 2, 3
- adaptive innate and additional study: 1
- adaptive innate and adjuvant setting: 1
- adaptive innate and liver increase: 1
- adaptive response and adjuvant setting: 1
Co phrase search for related documents, hyperlinks ordered by date